日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The potential impact of changing the Norwegian trauma Registry inclusion criteria for patients not admitted with trauma team activation: Identifying patient groups to be excluded and considering potential risks

改变挪威创伤登记处纳入标准（针对未启动创伤团队入院的患者）的潜在影响：确定应排除的患者群体并考虑潜在风险

期刊:European Journal of Trauma and Emergency Surgery
影响因子:2.2
doi:10.1007/s00068-026-03091-x
Nordberg, Synne; Holm, Kjetil Tengesdal; Weber, Clemens; Røise, Olav
发表日期：2026
文献求助 收藏

Mortality in polymyalgia rheumatica: a 38-year prospective population-based cohort study from Southern Norway

挪威南部一项为期38年的前瞻性人群队列研究：风湿性多肌痛患者的死亡率

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-025-03613-9
Tengesdal, Stig; Molberg, Øyvind; Holme, Øyvind; Gran, Jan Tore; Myklebust, Geirmund
发表日期：2025
文献求助 收藏

The Norwegian national trauma registry: development process and essential data insights

挪威国家创伤登记处：发展过程和关键数据洞察

期刊:Scandinavian Journal of Trauma Resuscitation & Emergency Medicine
影响因子:3.1
doi:10.1186/s13049-025-01390-7
Ringdal, Kjetil Gorseth; Holm, Kjetil Tengesdal; Røise, Olav
发表日期：2025
文献求助 收藏

Screening NLRP3 drug candidates in clinical development: lessons from existing and emerging technologies

NLRP3候选药物临床开发筛选：来自现有技术和新兴技术的经验教训

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1422249
Tengesdal, Isak W; Banks, Migachelle; Dinarello, Charles A; Marchetti, Carlo
NLRP3
LRP3
发表日期：2024
文献求助 收藏

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with Polymyalgia Rheumatica: a narrative review

挪威风湿病学会关于风湿性多肌痛患者诊断和治疗的建议：叙述性综述

期刊:BMC Rheumatology
影响因子:2.5
doi:10.1186/s41927-024-00422-6
Tengesdal, Stig; Diamantopoulos, Andreas P; Brekke, Lene Kristin; Besada, Emilio; Myklebust, Geirmund
发表日期：2024
文献求助 收藏

NLRP3 and cancer: Pathogenesis and therapeutic opportunities

NLRP3与癌症：发病机制和治疗机遇

期刊:Pharmacology & Therapeutics
影响因子:12.5
doi:10.1016/j.pharmthera.2023.108545
Tengesdal, Isak W; Dinarello, Charles A; Marchetti, Carlo
NLRP3
LRP3
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions

地塞米松和 OLT1177 协同抑制 STAT3 功能，减少黑色素瘤生长

期刊:Cells
影响因子:5.1
doi:10.3390/cells12020294
Alberto Dinarello, Taylor S Mills, Isak W Tengesdal, Nicholas E Powers, Tania Azam, Charles A Dinarello
肿瘤
黑色素瘤
发表日期：2023
文献求助 收藏

IL-38 Gene Deletion Worsens Murine Colitis

IL-38基因缺失加重小鼠结肠炎

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.840719
de Graaf, Dennis M; Wang, Ruth X; Amo-Aparicio, Jesús; Lee, J Scott; Dowdell, Alexander S; Tengesdal, Isak W; Marchetti, Carlo; Colgan, Sean P; Joosten, Leo A B; Dinarello, Charles A
IL-3
结肠炎
肠炎
发表日期：2022
文献求助 收藏

Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers

髓系细胞中宿主-NLRP3 炎症小体的激活决定了转移性乳腺癌对抗 PD-1 疗法的反应

期刊:Pharmaceuticals
影响因子:
doi:10.3390/ph15050574
Isak W Tengesdal, Suzhao Li, Nicholas E Powers, Makenna May, Charles P Neff, Leo A B Joosten, Carlo Marchetti, Charles A Dinarello
信号转导
肿瘤
乳腺癌
其它细胞
Functional/Block/Neutralize
炎性小体
Mouse
PDCD1
发表日期：2022
文献求助 收藏

Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion

靶向肿瘤来源的NLRP3可通过限制髓源性抑制细胞（MDSC）的扩增来减缓黑色素瘤的进展。

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2000915118
Tengesdal, Isak W; Menon, Dinoop R; Osborne, Douglas G; Neff, Charles P; Powers, Nicholas E; Gamboni, Fabia; Mauro, Adolfo G; D'Alessandro, Angelo; Stefanoni, Davide; Henen, Morkos A; Mills, Taylor S; De Graaf, Dennis M; Azam, Tania; Vogeli, Beat; Palmer, Brent E; Pietras, Eric M; DeGregori, James; Tan, Aik-Choon; Joosten, Leo A B; Fujita, Mayumi; Dinarello, Charles A; Marchetti, Carlo
黑色素瘤
MDSC
肿瘤
肿瘤免疫
LRP3
NLRP3
细胞生物学
发表日期：2021
文献求助 收藏